-- 2026年5月1日，高級副總裁保羅·坎寧安(Paul Cunningham)出售了1,000股Cadence Design Systems (CDNS)股票，套現337,490美元。根據向美國證券交易委員會(SEC)提交的4號表格文件，坎寧安目前控制該公司共127,586股普通股，其中127,586股為直接持有。 SEC文件連結： https://www.sec.gov/Archives/edgar/data/813672/000081367226000049/xslF345X05/wk-form4_1778015633.xml
Related Articles
Asia
Simcere Pharmaceutical Receives Chinese Regulatory Approval to Begin Trials of Tumor Drug
Simcere Pharmaceutical (HKG:2096) received Chinese regulatory approval to begin clinical trials of SIM0613, according to a Hong Kong bourse filing Wednesday.The injection is intended to treat advanced solid tumors and is licensed to Ipsen Pharma in regions outside Greater China.
$HKG:2096
Asia
Meitu Records 30% Rise in Paying Subscribers
Meitu (HKG:1357) said the number of paying subscribers using its platform grew 30% year on year to 17.90 million as of end March, according to a Hong Kong bourse filing Wednesday.Paying subscribers for the company's productivity tools grew 53% to 2.34 million, while leisure app subscribers increased 27% to 15.56 million, the firm said.The company's core revenue grew 34.3% year on year to 852 million yuan, while other businesses remained "stable overall."The company's annual recurring revenue for AI-driven productivity apps stood at 580 million yuan as of March, a 56% increase from a year earlier.
$HKG:1357
Asia
Yidu Tech Unit Wins SG$2.3 Million Singapore Healthcare Project
Yidu Tech (HKG:2158) said its subsidiary EVYD Research Private Limited won a contract from Singapore Health Services for the implementation and support of Dr Buddy, according to a Wednesday Hong Kong bourse filing.The total project amount is about SG$2.3 million.
$HKG:2158